Hemostasis & Tissue Sealing Agents Market - Global
Industry Insights and Forecast to 2025
Hemostasis is a physiological processes, which maintains fluidity of blood by preventing blood
loss from body. Hemostasis is characterized by clot formation by activating the natural
coagulation cascade. However, in cases of major surgeries and trauma, the blood loss is
excessive and cannot be stopped through natural healing process. Thus, hemostats and tissue
sealing agents aid in such situations by minimizing the blood loss and helps in healing the
injury. Hemostats and tissue sealing agents are increasingly being used, as excessive bleeding
during surgical procedures can lead to high risk. Moreover, excessive bleeding can also result in
postoperative complications that include prolonged surgical procedures and insufficient blood in
the body. According to In-Patient Epidemiology, a statistical survey conducted by Department of
Surgery, Division of Acute Care and Trauma Surgery, New York University 2012, blood loss
accounts for up to 31% of deaths in victims of trauma and catastrophic accident patients in the
U.S. Therefore, prevention of such occurrences is important for positive patient outcomes and
success of surgical procedures. Thus, topical hemostats in terms of mechanical hemostats, active
hemostats, and Flowable hemostats, that are solutions topically applied directly on the bleeding
site as well as natural and synthetic tissue sealants act as adjunct to natural hemostasis
procedure and are applied locally to control blood loss.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1567
Rising number of surgical procedures coupled with increasing trauma cases to foster global
hemostasis & tissue sealing agents market
Factors such as increasing number of surgical procedures as well as rising number of road
accidents are expected to significantly contribute to growth of the hemostasis and tissue sealing
agents market. For instance, according to Health and Social Care Information Centre (HSCIC),
surgery is one of the most important treatments offered by NHS care in the U.K., and
accounted for 4.7 million admissions across multiple sectors in 2013-14. The data also suggests
that the number of surgical procedures has increased by 27% between 2004 and 2014.
According to Centers of Disease Control and Prevention (CDC), around 200,000 deaths were
encountered in 2014, due to trauma injuries in the U.S. Increasing incidence of road accidents